The Company offers Quality and Compliance and Clinical Development consultancy to pharmaceutical and biotech companies across the globe. They help companies build robust Quality Management Systems and improve Regulatory Compliance across GXPs.
The Company is well positioned to provide a stable and profitable platform for growth. In 2022 with the secured contracts they have and the contracts under discussion, the Company could almost double their revenue. The Company has a reputation of excellence with a success rate of 90%. Solid relationships in the industry and a great team comprised of experienced industry veterans and up-and-coming talent provides an industry related company access to a well-established business.
In 2021, the Company yielded $9.6M in revenue with an Adjusted EBITDA of $5M. The Company is on track to achieve over $16.5M in revenue with $8.4M Adjusted EBITDA for 2022.
Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.